Evidence map›Paper›PMID 29084246›Full record

ArticlePloS one2017

Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand.

Phawinee Subsomwong, Muhammad Miftahussurur, Tomohisa Uchida, Ratha-Korn Vilaichone, Thawee Ratanachu-Ek, Varocha Mahachai, Yoshio Yamaoka

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Diagnostics (Basel, Switzerland) · 2026
    Article
  2. The Effect ofPathogens (Basel, Switzerland) · 2025
    Article
  3. Genotypic diversity of theJournal of medical microbiology · 2025
    Article
  4. Article
  5. Article
  6. Gastric mucosal precancerous lesions inWorld journal of gastroenterology · 2022
    Article
  7. Journal of inflammation research · 2022
    Article
  8. Article
  9. Article
  10. Discovery of unique AfricanWorld journal of gastroenterology · 2020
    Article
  11. The Potential Benefits of Vonoprazan asPharmaceuticals (Basel, Switzerland) · 2020
    Review
  12. Article
  13. Review
  14. Oncotarget · 2018
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Phawinee SubsomwongDepartment of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan.
Muhammad MiftahussururDepartment of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan.
Tomohisa UchidaDepartment of Molecular Pathology, Faculty of Medicine, Oita University, Hasama-machi, Yufu-City, Oita, Japan.
Ratha-Korn VilaichoneGastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathum Thani, Thailand.
Thawee Ratanachu-EkDepartment of Surgery, Rajavithi Hospital, Bangkok, Thailand.
Varocha MahachaiGI and Liver Center, Bangkok Medical Center, Bangkok, Thailand.
Yoshio YamaokaDepartment of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan.ORCID http://orcid.org/0000-0002-1222-5819
Michael E. DeBakey VA Medical Center · USOita University · JPBangkok Hospital · THRajavithi Hospital · THThammasat University Hospital · TH

Funding

REGULATION OF CXC CHEMOKINE EXPRESSION BY H. PYLORIR01DK062813 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI YAMAOKA, YOSHIO · 2004 to 2013
$3.0M
NIDDK NIH HHS R01 DK062813
6 · The paper itself

Abstract

Gastric cancer risk is varied among different regions of Thailand. We examined the characteristics of Helicobacter pylori infection in two regions of Thailand. The H. pylori status of 273 dyspeptic patients (136 from the South and 137 from the North; a low and high incidence of gastric cancer region, respectively) was evaluated, and virulence genotypes (cagA, vacA, hrgA and jhp0562-positive/β-(1,3)galT) were determined. The overall H. pylori infection rate was 34.1% (93/273). The prevalence was higher in the North than in the South (50.4% vs. 17.6%, P <0.001) and was significantly higher among individuals with the following characteristics: low income, birthplace in the Northeast or North regions, agricultural employment, or consumption of alcohol or unboiling water. Among these socio-demographic determinants, region was an independent risk factor for H. pylori infection (odds ratio = 6.37). Patients including both H. pylori infected and uninfected cases who lived in the North had significantly more severe histological scores than those in the South. In contrast, among H. pylori-positive cases, patients in the South had significantly more severe histological scores than those in the North. Of the 74 strains cultured, 56.8% carried Western-type cagA, with a higher proportion in the South than in the North (76.2% vs. 49.1%, P = 0.05). In disagreement with the current consensus, patients infected with the Western-type cagA strains had more severe inflammation scores in the antrum than those infected with the East Asian-type cagA strains (P = 0.027). Moreover, Western-type cagA strains induced more severe histological scores in patients from the South than those of either genotype from the North. Other virulence genes had no influence on histological scores. The incidence of gastric cancer in Thailand was different among regions and corresponded to differences in the prevalence of H. pylori infection. More careful follow-up for patients in the South will be required, even if they are infected with H. pylori carrying Western-type cagA.

Indexed as

Genes, BacterialCross-Sectional StudiesGastric MucosaGenotypeHelicobacter InfectionsHelicobacter pyloriHumansInterleukin-8PrevalenceRisk FactorsStomach NeoplasmsThailandVirulenceInterleukin-8

Identifiers

PMID29084246
PMCPMC5662176
OpenAlexW2766188047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.